Fexofenadine as Adjuvant Therapy in Parkinson Disease
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Recruiting · NCT06785298 · Registry updated 2026-01-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fexofenadine as Adjuvant Therapy in Parkinson Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 2 / Phase 3 | 2026-01-21 | NCT06785298 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tanta University | 261 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tanta University | Tanta | Egypt | 2 |